BSE Live
Dec 09, 15:29Prev. Close
327.05
Open Price
326.55
Bid Price (Qty.)
332.75 (38)
Offer Price (Qty.)
342.00 (345)
NSE Live
Dec 09, 15:29Prev. Close
326.80
Open Price
325.00
Bid Price (Qty.)
335.40 (60)
Offer Price (Qty.)
341.70 (3)
| Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -7.95 | 1.48 | 12.81 | 1,448.81 | -145.03 | |
| Net CashFlow From Operating Activities | -27.37 | -0.10 | -422.45 | -108.44 | 106.76 | |
| Net Cash Used In Investing Activities | 64.98 | 10.23 | 430.33 | 1,282.57 | -47.68 | |
| Net Cash Used From Financing Activities | -2.66 | -2.81 | -18.37 | -1,175.85 | -47.11 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 34.95 | 7.32 | -10.50 | -1.73 | 11.98 | |
| Cash And Cash Equivalents Begin of Year | 47.17 | 39.85 | 50.35 | 52.08 | 40.22 | |
| Cash And Cash Equivalents End Of Year | 82.13 | 47.17 | 39.85 | 50.35 | 52.19 |
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y